Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Botti

Showing results (141-150 of 153) with videos related to

Pageof 16
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|August 28, 1999
The integrated treatment of peritoneal carcinomatosis. A preliminary experienceF Cavaliere, F Di Filippo, M Cosimelli, et al.
La Clinica Terapeutica|January 27, 2009
Optimal sequence of anthracyclines and taxanes as adjuvant breast cancer treatmentP Vici, G Viola, S Rossi, et al.
La Clinica Terapeutica|January 27, 2009
Docetaxel in the adjuvant therapy of HER-2 positive breast cancer patientsP Vici, G Viola, C Botti, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 14, 2006
Doxorubicin in isolation limb perfusion in the treatment of advanced limb soft tissue sarcomaF Di Filippo, R Garinei, M Anzà, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 4, 2000
Peritonectomy and hyperthermic antiblastic perfusion in the treatment of peritoneal carcinomatosisF Cavaliere, F Di Filippo, C Botti, et al.
Breast Cancer Research and Treatment|October 12, 1999
Breast cancer and timing of surgery during menstrual cycle: a 5-year analysis of 248 premenopausal womenM Milella, C Nisticò, V Ferraresi, et al.
European Journal of Nuclear Medicine|May 1, 1997
Comparison of three different methods for radiolabelling human activated T lymphocytesC Botti, D R Negri, E Seregni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal studyF Guadagni, P Ferroni, S Carlini, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 5, 1999
Hyperthermic antiblastic perfusion with alpha tumor necrosis factor and doxorubicin for the treatment of soft tissue limb sarcoma in candidates for amputation: results of a phase I studyF Di Filippo, C R Rossi, M Vaglini, et al.
Breast Cancer Research and Treatment|October 27, 2001
Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancerR D'Alessandro, M Roselli, P Ferroni, et al.
Pageof 16

Showing results (141-150 of 153) with videos related to

Sort By:
Pageof 16
Journal of Experimental & Clinical Cancer Research : CR|August 28, 1999
The integrated treatment of peritoneal carcinomatosis. A preliminary experienceF Cavaliere, F Di Filippo, M Cosimelli, et al.
La Clinica Terapeutica|January 27, 2009
Optimal sequence of anthracyclines and taxanes as adjuvant breast cancer treatmentP Vici, G Viola, S Rossi, et al.
La Clinica Terapeutica|January 27, 2009
Docetaxel in the adjuvant therapy of HER-2 positive breast cancer patientsP Vici, G Viola, C Botti, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 14, 2006
Doxorubicin in isolation limb perfusion in the treatment of advanced limb soft tissue sarcomaF Di Filippo, R Garinei, M Anzà, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 4, 2000
Peritonectomy and hyperthermic antiblastic perfusion in the treatment of peritoneal carcinomatosisF Cavaliere, F Di Filippo, C Botti, et al.
Breast Cancer Research and Treatment|October 12, 1999
Breast cancer and timing of surgery during menstrual cycle: a 5-year analysis of 248 premenopausal womenM Milella, C Nisticò, V Ferraresi, et al.
European Journal of Nuclear Medicine|May 1, 1997
Comparison of three different methods for radiolabelling human activated T lymphocytesC Botti, D R Negri, E Seregni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal studyF Guadagni, P Ferroni, S Carlini, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 5, 1999
Hyperthermic antiblastic perfusion with alpha tumor necrosis factor and doxorubicin for the treatment of soft tissue limb sarcoma in candidates for amputation: results of a phase I studyF Di Filippo, C R Rossi, M Vaglini, et al.
Breast Cancer Research and Treatment|October 27, 2001
Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancerR D'Alessandro, M Roselli, P Ferroni, et al.
Pageof 16